Regulatory Fibroblast-Like Synoviocytes Cell Membrane Coated Nanoparticles: A Novel Targeted Therapy for Rheumatoid...

Area of Science:

• Immunology
• Cell Biology
• Biomaterials Science

Background:

• Fibroblast-like synoviocytes (FLS) are key cells in rheumatoid arthritis (RA) joint inflammation.
• In RA, FLS exhibit a proinflammatory phenotype instead of their usual regulatory function, perpetuating inflammation.
• The signals controlling FLS heterogeneity in inflammatory environments are not fully understood.

Purpose of the Study:

• To investigate how cytokines modulate FLS phenotypes.
• To develop a novel biomimetic therapeutic strategy for RA based on regulatory FLS.

Main Methods:

• Inducing regulatory FLS (FLS^reg) using interferon-gamma (IFN-γ) and rapamycin.
• Developing nanoparticles coated with FLS^reg-derived cell membranes (FIRN).
• Evaluating FIRN efficacy, stability, and targeting in an RA mouse model.

Main Results:

• Interferon-gamma (IFN-γ) induces a regulatory FLS phenotype (FLS^reg) with inhibitory molecule expression.
• Rapamycin enhances IFN-γ's effect on FLS.
• FIRN demonstrated efficacy, stability, and targeted inflammation reduction in an RA mouse model.

Conclusions:

• Cytokines differentially modulate FLS phenotypes within inflammatory microenvironments.
• Regulatory FLS hold potential for developing novel therapeutic strategies for autoimmune diseases like RA.
• FIRN represents a promising biomimetic approach for RA treatment.